Loading…
CIK 0001587114 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("ecor1-capital-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADS | $6.6M | 0.4% | 27,404,070 SH | New |
| AKERO THERAPEUTICS INC | COM | $23.5M | 1.4% | 440,000 SH | New |
| ALKERMES PLC | SHS | $14.3M | 0.8% | 500,000 SH | New |
| ANAPTYSBIO INC | COM | $174.9M | 10.4%Prev: 18.5% | 7,880,094 SH | Decreased |
| APELLIS PHARMACEUTICALS INC | COM | $205.9M | 12.2% | 11,895,808 SH | New |
| ATARA BIOTHERAPEUTICS INC | COM NEW | $4.4M | 0.3%Prev: 0.0% | 573,183 SH | Increased+473,590 SH |
| AVIDITY BIOSCIENCES INC | COM | $14.2M | 0.8% | 500,000 SH | New |
| CRINETICS PHARMACEUTICALS IN | COM | $123.3M | 7.3%Prev: 6.6% | 4,288,120 SH | Decreased |
| CRISPR THERAPEUTICS AG | NAMEN AKT | $67.6M | 4.0%Prev: 2.8% | 1,389,276 SH | Increased |
| DAY ONE BIOPHARMACEUTICALS I | COM | $5.6M | 0.3% | 862,068 SH | New |
| ETON PHARMACEUTICALS INC | COM | $28.9M | 1.7%Prev: 2.3% | 2,030,544 SH | Decreased-141,394 SH |
| GALAPAGOS NV | SPON ADR | $29.0M | 1.7%Prev: 2.1% | 1,036,945 SH | Decreased-630,174 SH |
| HILLEVAX INC | COM | $4.8M | 0.3% | 2,420,243 SH | New |
| IMMUNOME INC | COM | $37.9M | 2.2% | 4,079,415 SH | New |
| ITEOS THERAPEUTICS INC | COM | $106.6M | 6.3% | 10,688,978 SH | New |
| JANUX THERAPEUTICS INC | COM | $34.0M | 2.0% | 1,469,818 SH | New |
| JAZZ PHARMACEUTICALS PLC | SHS USD | $181.1M | 10.7%Prev: 13.7% | 1,706,469 SH | Decreased |
| KURA ONCOLOGY INC | COM | $24.2M | 1.4% | 4,200,000 SH | New |
| MACROGENICS INC | COM | $1.9M | 0.1% | 1,602,717 SH | New |
| MADRIGAL PHARMACEUTICALS INC | COM | $22.7M | 1.3% | 75,000 SH | New |
| MBX BIOSCIENCES INC | COM | $13.1M | 0.8%Prev: 1.0% | 1,149,794 SH | Decreased+372,794 SH |
| METSERA INC | COM | $7.7M | 0.5% | 271,529 SH | New |
| NEUROGENE INC | COM | $19.0M | 1.1%Prev: 1.1% | 1,271,342 SH | Decreased |
| NUVATION BIO INC | *W EXP 02/10/202 | $1.9M | 0.1% | 963,333 SH | New |
| ORIC PHARMACEUTICALS INC | COM | $16.4M | 1.0%Prev: 3.6% | 1,618,068 SH | Decreased-5,110,048 SH |
| PACIRA BIOSCIENCES INC | COM | $10.9M | 0.6% | 457,471 SH | New |
| REPLIMUNE GROUP INC | COM | $7.9M | 0.5%Prev: 0.3% | 850,341 SH | Increased-149,659 SH |
| SURROZEN INC | *W EXP 08/01/203 | $596K | 0.0%Prev: 0.0% | 66,665 SH | Increased+62,221 SH |
| TANGO THERAPEUTICS INC | COM | $54.4M | 3.2% | 10,630,736 SH | New |
| TECTONIC THERAPEUTIC INC | COM | $18.6M | 1.1% | 935,121 SH | New |
| UNIQURE NV | SHS | $57.5M | 3.4% | 4,123,971 SH | New |
| VERONA PHARMA PLC | SPONSORED ADS | $18.9M | 1.1% | 200,000 SH | New |
| VOYAGER THERAPEUTICS INC | COM | $12.2M | 0.7% | 3,917,546 SH | New |
| WHITEHAWK THERAPEUTICS INC | COM | $2.0M | 0.1% | 1,091,417 SH | New |
| XENCOR INC | COM | $48.3M | 2.9%Prev: 1.1% | 6,144,767 SH | Increased+3,961,767 SH |
| ZYMEWORKS INC | COM | $288.3M | 17.1%Prev: 24.4% | 22,970,388 SH | Decreased |
| 13F-HR |
| 0000935836-26-000415 |
| $2.06B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000935836-25-000506 | $1.69B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000935836-26-000270 | $2.36B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000935836-25-000338 | $1.69B | View |